Immuron
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immuron and other ETFs, options, and stocks.About IMRN
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. It operates through the Hyper-immune Products and Research and Development (R&D) segments.
CEOSteven Lydeamore
CEOSteven Lydeamore
Employees—
Employees—
HeadquartersBlackburn, Victoria (VIC)
HeadquartersBlackburn, Victoria (VIC)
Founded1994
Founded1994
Employees—
Employees—
IMRN Key Statistics
Market cap7.58M
Market cap7.58M
Price-Earnings ratio-1.56
Price-Earnings ratio-1.56
Dividend yield—
Dividend yield—
Average volume112.57K
Average volume112.57K
High today$0.943
High today$0.943
Low today$0.909
Low today$0.909
Open price$0.92
Open price$0.92
Volume36.15K
Volume36.15K
52 Week high$2.48
52 Week high$2.48
52 Week low$0.909
52 Week low$0.909
Stock Snapshot
With a market cap of 7.58M, Immuron(IMRN) trades at $0.91. The stock has a price-to-earnings ratio of -1.56.
As of 2025-12-24, Immuron(IMRN) stock has fluctuated between $0.91 and $0.94. The current price stands at $0.91, placing the stock +0.1% above today's low and -3.5% off the high.
Immuron(IMRN) shares are trading with a volume of 36.15K, against a daily average of 112.57K.
In the last year, Immuron(IMRN) shares hit a 52-week high of $2.48 and a 52-week low of $0.91.
In the last year, Immuron(IMRN) shares hit a 52-week high of $2.48 and a 52-week low of $0.91.